DataMEDS AI enters LOI to acquire QLPM IP, expand Datavault license, and take control of Tollo Health

Wellgistics Health, Inc.

MEDS to acquire QLPM IP from EOS and Scilex, expand Datavault AI Health license, and acquire controlling interest in Tollo Health (HLH).
Post-closing ownership: EOS 19.9%, Scilex 19.9%, Datavault 19.9%, HBA 24.9%, Fortitude 5%, existing public ~10.4%.
Gerald Commissiong appointed Interim Co-CEO; Dan Hirsch hired as Interim VP of Finance.
Transaction subject to due diligence, definitive agreements, fairness opinion, stockholder and Nasdaq approvals; no assurance of completion.
Minimum $2M investment from Dawson James investors; ATM facility to be filed within 14 days.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.